Does BCR-ABL transcript type influence the prognosis of patients in chronic myelogenous leukemia chronic phase?

MLA

T.P. de Almeida Filho, et al. “Does BCR-ABL Transcript Type Influence the Prognosis of Patients in Chronic Myelogenous Leukemia Chronic Phase?” Hematology, Transfusion and Cell Therapy, vol. 41, no. 2, Apr. 2019, pp. 114–18. EBSCOhost, https://doi.org/10.1016/j.htct.2018.10.003.

APA

T.P. de Almeida Filho, P.A. Maia Filho, Maritza Cavalcante Barbosa, Luana Letícia Alves Dutra, Marilena Facundo de Castro, Fernando Barroso Duarte, Acy Telles de Souza Quixadá, & Romélia Pinheiro Gonçalves Lemes. (2019). Does BCR-ABL transcript type influence the prognosis of patients in chronic myelogenous leukemia chronic phase? Hematology, Transfusion and Cell Therapy, 41(2), 114–118. https://doi.org/10.1016/j.htct.2018.10.003

Chicago

T.P. de Almeida Filho, P.A. Maia Filho, Maritza Cavalcante Barbosa, Luana Letícia Alves Dutra, Marilena Facundo de Castro, Fernando Barroso Duarte, Acy Telles de Souza Quixadá, and Romélia Pinheiro Gonçalves Lemes. 2019. “Does BCR-ABL Transcript Type Influence the Prognosis of Patients in Chronic Myelogenous Leukemia Chronic Phase?” Hematology, Transfusion and Cell Therapy 41 (2): 114–18. doi:10.1016/j.htct.2018.10.003.